Pfizer Raises 2021 Forecast, But Sees Shot Sales Falling Next Year

(Bloomberg) — Pfizer Inc. raised its full-year forecast on the strength of Covid-19 vaccine sales and provided its first glimpse at potential gains for 2022, projecting $29 billion in sales from the shot it developed with BioNTech SE. 

Most Read from Bloomberg…

Click here to view the original article.